Sovereign AI fund supports Hassabis startup, Isomorphic

Isomorphic Labs, a company founded by Demis Hassabis , which uses frontier artificial intelligence (AI) for drug design and development, has received investment from the UK government’s Sovereign AI fund. Isomorphic’s work builds on the breakthrough success of DeepMind’s AlphaFold, the AI model co-created by Hassabis that demonstrated in 2016 how AI could beat the Go world champion, Leo Sedol. The company is developing a number of proprietary breakthrough AI models, which together form its unified drug design engine across multiple therapeutic areas and drug modalities. Backing AI innovators, founders and entrepreneurs Launched in April, the Sovereign AI fund provides grants of £1m up to £9m to fund the creation of strategic AI assets. The programme is initially aimed at high-value AI datasets and autonomous or automated laboratory infrastructure. It is open to UK-registered companies, research organisations, universities and consortia with a credible plan that aligns with the Sovereig